Cargando…
LincRNA‐p21 alleviates atherosclerosis progression through regulating the miR‐221/SIRT1/Pcsk9 axis
Atherosclerosis (AS) is the main aetiology of coronary heart disease, cerebral infarction and peripheral vascular disease in humans. Long‐noncoding RNA (LincRNA)‐p21 has been reported to participate in the development of AS. Therefore, this study was designed to investigate the mechanism of LincRNA‐...
Autores principales: | Wang, Haojie, He, Fei, Liang, Bing, Jing, Yuanhu, Zhang, Pei, Liu, Weichao, Zhu, Bowen, Dou, Dongmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500963/ https://www.ncbi.nlm.nih.gov/pubmed/34541816 http://dx.doi.org/10.1111/jcmm.16771 |
Ejemplares similares
-
LincRNA-p21: Implications in Human Diseases
por: Tang, Sai-Sai, et al.
Publicado: (2015) -
Decreased FENDRR and LincRNA-p21 expression in atherosclerotic plaque
por: Çekin, Nilgün, et al.
Publicado: (2018) -
Lionheart LincRNA alleviates cardiac systolic dysfunction under pressure overload
por: Kuwabara, Yasuhide, et al.
Publicado: (2020) -
LincRNA-p21 activates endoplasmic reticulum stress and inhibits hepatocellular carcinoma
por: Ning, Yang, et al.
Publicado: (2015) -
Tubule-specific deletion of LincRNA-p21ameliorates lipotoxic kidney injury
por: Li, Bin, et al.
Publicado: (2021)